article · Epidemiology and Health System Journal
Background and aims: Peritoneal dialysis (PD) remains underused despite being a valid alternative to hemodialysis. This study assessed patients’ clinical profiles, technique survival, and mortality at Morocco’s first PD center. Methods: This retrospective study evaluated 247 patients treated with PD from June 2006 to May 2025, with no exclusions. Required data were obtained from the French-language PD Registry and medical records. Finally, t-tests, ANOVA, chi-square tests, and stepwise backward logistic regression were used for statistical analysis (P<0.05). Results: Overall, 233 (94.3%) patients chose PD as their renal replacement therapy (RRT). The average age was 47.5±17.3 years. In addition, 62.7% were male, and 25.4% had diabetes. The median follow-up period was 4.0 years, with an interquartile range of 2.0–7.0. Technique survival rates at 1, 3, and 5 years were 90%, 55%, and 45%, respectively. In addition, patient survival rates were 88%, 65%, and 50%. The incidence of peritonitis was 0.48 episodes per patient-year and was the primary cause of technique failure (53.6%) and contributed to 11.9% of deaths. Logistic regression demonstrated a technique failure associated with diabetes (P=0.038). Mortality was linked to age>60 (P=0.022), vascular access failure (P=0.013), and assisted PD (P=0.003). Hypoalbuminemia (P=0.281), anemia (P=0.176), and hypophosphatemia (P=0.223) were not significant. Conclusion: PD is a long-term RRT in Morocco. Mortality is linked to advanced age, vascular access failure, and assisted PD. Continued patient education and staff training are vital.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.34172/ehsj.26438
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.